Stephanie specialises in inbound investment into Indonesia, public and private M&A, and joint ventures. She advises local business groups and major foreign investors on their joint ventures, and growth companies and venture capital funds on fundraisings and corporate restructurings. She covers a broad range of sectors, with a particular focus on the healthcare sector.
Her clients include local business groups and conglomerates, blue chip multinationals, and international private equity firms. She is accustomed to dealing with international clients investing in Indonesia and providing legal advice to international standards.
Stephanie has advised:read more
Stephanie specialises in inbound investment into Indonesia, public and private M&A, and joint ventures. She advises local business groups and major foreign investors on their joint ventures, and growth companies and venture capital funds on fundraisings and corporate restructurings. She covers a broad range of sectors, with a particular focus on the healthcare sector.
Her clients include local business groups and conglomerates, blue chip multinationals, and international private equity firms. She is accustomed to dealing with international clients investing in Indonesia and providing legal advice to international standards.
Stephanie has advised:
- Kopi Kenangan, an Indonesian coffee shop chain, on its Series C fundraising, which made the group the first New Retail F&B Unicorn in Southeast Asia
- LinkAja, the SOE-backed digital payment platform, on a strategic investment by Grab, Southeast Asia’s leading super app, in its Series B funding round, being the first investment by a major technology company in LinkAja
- Silk Road Fund, a state-owned investment fund of the Chinese government, on its proposed investment into Kimia Farma
- a private equity firm on a significant investment in a major Indonesian company group engaging in healthcare services, including hospitals, laboratories and clinics, structured through a combination of loans, options and convertible bonds
- Tunggal Group, a leading Indonesian pharmaceuticals group, on its sale in PT Aventis Pharma alongside Sanofi to PT Kalbe Farma Tbk
- PT Omni Healthcare, an Indonesian hospital group, on the sale of its controlling stake in hospital operator PT Sarana Meditama Metropolitan Tbk to PT Elang Mahkota Teknologi Tbk (Emtek), one of Indonesia’s largest media and tech solutions companies, which has been expanding its portfolio to include healthcare operations
- Barito Pacific Group on its sale of certain forest concessions and plywood processing assets to Sampoerna Kayoe Group
- KKR on its acquisition of Unilever’s margarine and spreads business in Indonesia as part of the US$8 billion global acquisition of Unilever’s margarine and spreads business, including Indonesian licencing, asset transfer and employment matters.
Read less
